WAKIX® (pitolisant) Net Revenue of $172.8 Million for Second Quarter 2024; ~29% Growth Year-over-Year Next Generation Pitolisant High-Dose (HD) Program…
Company to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Anavex…
BURLINGTON, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the…
Garvan Institute's TenK10K Project Aims to Map 50 Million Human Cells from 10,000 People PLEASANTON, Calif., Aug. 5, 2024 /PRNewswire/…
PRINCETON, N.J., Aug. 5, 2024 /PRNewswire/ -- WCG, the global leader in providing solutions that measurably improve the quality and…
Innovative partnership delivers cutting-edge vocal biomarker technology to veteran entrepreneurs, empowering them to enhance mental health and business success CHICAGO,…
NEWARK, Del., Aug. 5, 2024 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals is pleased to announce two…
CARMEL, Ind., Aug. 5, 2024 /PRNewswire/ -- Orchard Software is pleased to announce that it has been ranked the number one…
In 2022 breast cancer was the most common cancer in women in 157 countries out of 185, and lung cancer…
LOUISVILLE, Ky., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected by Genentech,…